Conclusions
VKH is a rare and potentially debilitating disorder in which severe
complications can be avoided by early diagnosis and adequate treatment.
It is imperative to keep up with advancing radiological and
technological advancements to enable optimization of the rate of VKH
diagnosis. Corticosteroids and immunosuppressants remain the mainstay of
treatment for VKH. COVID-19 would be a potential immunological trigger
of VKH in our patient if COVID-19 infection onset was prior to the
2-week history of VKH symptom onset or during VKH prodromal phase.
Further investigation is necessary to establish whether this hypothesis
is valid.
Keywords: VKH, COVID-19, comorbid, rare, infectious disease,